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Hyperlipidaemia has been incriminated as a risk factor 
in coronary heart disease (CHD) and atherosclerosis,1,2 in 
addition to other risk factors including diabetes mellitus 
(DM). DM affects several lipid metabolism mechanisms. 
Low insulin levels in type 1 DM are associated with high 
levels of chylomicrons and very-low-density lipoprotein 
(VLDL) and lipoprotein lipase deficiency, resulting in 
hypertriglyceridaemia. Such hyperlipidaemia improves with 
tighter control of type 1 DM. Obesity and insulin resistance 
result in hypertriglyceridaemia due to overproduction 
of VLDL. Management of hyperlipidaemia in type 2 DM 
involves rigorous dietary and drug treatment. Treatment of 
hyperlipidaemia has been shown to benefit DM patients in 
decreasing CHD risk.2-4
   In a study of DM patients in Ethiopia,5 18.5% and 
14.2% were found to have hypercholesterolaemia and 
hypertriglyceridaemia respectively. In the same study 
hypercholesterolaemia was found in a high proportion of 
females and type 2 DM patients. In a report from the third US 
National Health and Nutrition Examination Survey and the 
Behavioral Risk Factors Surveillance System6 which monitored 
4 085 adults with diabetes, 58% had serum low-density 
lipoprotein (LDL) cholesterol levels greater than or equal to 3.4 
mmol/l. Of the 2 481 patients aged over 45 years studied in 
the UK to assess the universal screening of diabetes in general 
practice, 73% (45 - 92%) had a cholesterol level > 5 mmol/l.7 In 
a cross-sectional survey in South Africa8 undertaken to assess 
dietary patterns in type 2 DM patients (133 men, 155 women), 
high triglyceride levels were detected in 24 - 25% of men and 
in 17 - 18% of women. 
Subjects and methods
A cross-sectional study was carried out in Gaborone, Botswana. 
The study subjects were all DM patients receiving diabetic care 
at 14 Gaborone City Council (GCC) clinics. A medical officer 
examined the patients and administered a questionnaire, and 
patients were sent for laboratory investigations. Glycosylated 
haemoglobin, serum cholesterol, triglyceride, high-density 
lipoprotein (HDL) and LDL levels were determined by the 
Botswana National Laboratory using Cobas Integra 400. The 
study period was between 1 December 2003 and 28 February 
2004. All subjects who gave consent were included in the study. 
   Overweight was defined as a body mass index (BMI) > 25 
up to 30 and obesity as BMI > 30. Hypercholesterolaemia 
was defined as total cholesterol > 5.3 mmol/l, while 
hypertriglyceridaemia was defined as > 1.82 mmol/l.
   The questionnaire was coded and analysed using EpiInfo 
2002. Analysis of variance (ANOVA), t-test, chi-square test, 
correlation and regression analysis were used. PubMed was 
used to search for the relevant literature.
Results
Four hundred and one patients with DM participated in the 
study, of whom 287 (71.6%) were female and 114 (28.4%) 
male. The mean age of the subjects was 53.8 years (standard 
deviation (SD) 12.2 years). The mean glycosylated haemoglobin 
was 9.56% (SD 2.6%). Of the subjects 61.2% had hypertension, 
27.2% were overweight (BMI > 25 up to 30), 56.4% were obese 
(BMI > 30), 4% had a history of smoking and 3.1% had a 
history of alcohol intake. Only 13.7% did regular exercise.
   The mean serum cholesterol level was 4.9 mmol/l and 33.5% 
of the subjects had serum cholesterol levels higher than 5.3 
mmol/l. There was no difference (p = 0.17) in mean serum 
cholesterol level between males (4.99 mmol/l) and females 
(4.77 mmol/l). There was no significant difference in mean 
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A cross-sectional study was undertaken to determine the 
serum lipid profile of diabetes mellitus (DM) patients 
receiving treatment at Gaborone City Council clinics. A total 
of 401 patients were studied over a 3-month period. It was 
found that 33.5% had hypercholesterolaemia and 38.9% 
hypertriglyceridaemia. The mean low-density lipoprotein 
(LDL) levels were higher in females than in males, but there 
was no difference in LDL levels between type 1 and 2 DM 
patients. There was no difference in cholesterol, triglyceride 
and high-density lipoprotein (HDL) levels between genders or 
between type 1 and 2 patients. Hyperlipidaemia was associated 
with high body mass index. Only hypertriglyceridaemia was 
associated with high blood pressure. Hyperlipidaemia was not 
associated with exercise, smoking or alcohol consumption in 
the DM patients studied.
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HbA1c between DM patients with normal cholesterol levels and 
those with hypercholesterolaemia (p = 0.45). The mean serum 
triglyceride level was 1.79 mmol/l; 38.9% of DM patients 
had serum triglyceride levels higher than 1.82 mmol/l. There 
was no difference (p = 0.09) in mean serum triglyceride level 
between males (1.73 mmol/l) and females (1.92 mmol/l). There 
was no difference between type 1 and type 2 DM patients with 
regard to serum cholesterol (p = 0.77) or triglyceride levels (p 
= 0.22). There was no significant difference in mean HbA1c 
between DM patients with normal triglyceride levels and those 
with hypertriglyceridaemia (p = 0.07).
   The mean HDL level was 1.27 mmol/l; 11.4% of patients had 
an HDL level above 1.6 mmol/l. There was no difference in 
HDL levels between males and females (p = 0.64) or between 
type 1 and 2 DM patients (p = 0.99). The mean LDL level was 
3.44 mmol/l; 58.2% of patients had an LDL level higher than 
3.36 mmol/l. LDL levels were higher in females (3.54 mmol/l) 
than males (3.14 mmol/l) (t = 2.01, p = 0.04), but there was no 
difference in LDL levels between type 1 and 2 DM patients  
(p = 0.87).
   Hypercholesterolaemia was associated with overweight (r^2 
= 0.03, F = 6.88, p = 0.009) and obesity (r^2 = 0.03, F = 8.02, p = 
0.0048). Hypertriglyceridaemia was associated with overweight 
(r^2 = 0.03, F = 6.79, p = 0.0095) and obesity (r^2 = 0.03, F = 7.7, 
p = 0.0057). Hyperlipidaemia was not associated with exercise, 
smoking or alcohol consumption. Variables included in the 
regression were age, sex, BMI, serum lipid levels, hypertension, 
alcohol consumption, smoking and exercise.
Discussion
In the study about one-third of the DM patients had 
hypercholesterolaemia and about half had hypertriglyceri-
daemia. This finding is higher than other reports from Africa,5,8 
but lower than reports from the UK.7 Similar to the findings 
of a USA survey,6 the majority of DM patients had LDL levels 
higher than 3.36 mmol/l, which is considered to pose a risk of 
CHD and atherosclerosis. Only a few of the DM patients were 
found to have HDL levels higher than 1.6 mmol/l, which is 
associated with low risk of CHD and atherosclerosis. When 
such lipid profiles co-exist with high levels of overweight and 
obesity among DM patients, a high incidence of CHD and 
atherosclerosis may be inevitable in the future. 
   The study showed that obesity is strongly associated with 
elevated plasma lipid levels. Hyperlipidaemia was not 
associated with exercise, smoking or alcohol consumption. 
Except for LDL levels, which tend to be higher in female DM 
patients, there was no significant difference between males and 
females with regard to the other plasma lipid levels.
Conclusion
Hyperlipidaemia is a common finding among DM 
patients. DM patients should be screened and appropriate 
management should be instituted to reduce the risk of CHD 
and atherosclerosis. Further studies should be undertaken to 
establish dietary patterns in Botswana and other factors that 
may lead to hyperlipidaemia.
   Acknowledgement: Ministry of Health Research Unit and 
Gaborone city council clinics.
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Table I.  Mean serum lipid levels among male and female 
diabetes mellitus patients in Gaborone City Council 
clinics, Gaborone, Botswana, 2004
  Cholesterol Triglyceride HDL LDL 
 N (%) (mmol/l) (mmol/l) (mmol/l) (mmol/l)
Male         114 (28.4)   4.99 1.82 Mean   3.14
Female     287 (71.6)   4.77 1.92 1.27   3.54
   Total        401   (NS) 
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